Apply for AMR Grant

 ISAC is now accepting Project Grant applications to fund antimicrobial research in low- to middle- income countries from ISAC Member Society applicants**

Applications are invited for grants between £5,000 and £10,000.

Aim of Research Project

Applicants are required to demonstrate that ISAC funds will be utilised for a clearly defined piece of research, which will have an identifiable outcome on completion of the work. At least one country involved must be a low- to middle- income country.

Research projects should address one of the three following areas:

• What are feasible and effective prevention strategies to prevent transmission of (resistant) pathogens in low resource settings?
• What basic laboratory support does a healthcare system minimally need to tackle infectious diseases?
• How do we improve antimicrobial use worldwide to ensure it is delivered only to those who need it?

Project Criteria

• Projects can last up to 24 months.
• 6-monthly updates are required.
• Funds can be used for staff or materials.
• At least two institutions should be involved in the project of which at least one is from a low- or middle-income country.

Eligibility of applicants

• Principal applicant must be a member of an ISAC Member Society. Visit the website to see the full list of ISAC Member Societies.
• Other applicants do not need to be a member of an ISAC Member Society.
• The principal applicant must be the principal investigator on the intended research.
• At least one country involved must be a low- to middle- income country.
  

Application Process

To apply for a grant, applicants will be required to submit the following:

• An application form.
• Proof of Member Society membership.
• A Curriculum Vitae (one page) of the main applicants.
• Confirmation of the application from the Head of Department and confirmation that the Department has the resources required to undertake the project.
• Please send your completed application form and supporting documents to secretariat@ISAC.world.

Terms and Conditions

• International Society of Antimicrobial Chemotherapy to be acknowledged on all resulting publications and presentations.
• 6-monthly progress reports to be submitted to the ISAC Executive Committee.
• Research funds to be used for the project, as per the budget application only.
  ISAC does not support indirect costs to institutions.
• Applications / reports to be written in English.
• Only one application per applicant per year.
• Grant applications will be assessed by a panel of independent reviewers / the ISAC Executive Committee, using a standardised scoring system.
  
  
  

Deadline: 1 September 2021

Click here to download the application form.
For more information, please contact secretariat@ISAC.world.

We are delighted to announce the awardees of the 2020 ISAC Project Grants.

The decision on which projects to fund was difficult – we received many more applications than we could fund and the competition was strong. But after careful consideration by a panel of experts, three important projects were selected that address research gaps with demonstrable and achievable goals.

The 2020 ISAC Project Grant awardees are:

PUTERI JUANITA ZAMRI, Hospital Selayang, Malaysia
Optimized Doses of Polymyxins to Improve Outcomes for Non-Critically Ill and Critically Ill Patients with Multidrug-resistant (MDR) Gram-negative Bacterial Infections
PUTERI JUANITA BINTI ZAMRI is a senior clinical pharmacist experienced in managing critically ill patients especially focusing in infectious diseases management. She is currently interested in the research area of infectious diseases & pharmacokinetics/pharmacodynamics of antibiotics. She is now serving the Ministry of Health Malaysia, and currently affiliated as a PhD student in the University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland, Brisbane Australia. Her project, “Optimized Doses of Polymyxins to Improve Outcomes for Non-Critically Ill and Critically Ill Patients with Multidrug-resistant (MDR) Gram-negative Bacterial Infection” will focus on the pharmacokinetics of colistin and polymyxin B in Malaysian patients, and to develop clinically-relevant dosing guidelines in the treatment of MDR A. baumannii and P. aeruginosa infections for Malaysian hospitals.
Puteri is a member of ISAC Member Society, the Malaysian Society of Infectious Diseases and Chemotherapy (MSIDC).

ERIC KOFI NGYEDU, Cape Coast Teaching Hospital, Ghana
Assessing the prevalence and drivers of over-the-counter sales of antibiotics among community pharmacies and over the counter medicine sellers in Ghana to develop mitigatory behaviour change interventions to tackle AMR
Dr. Eric Kofi Ngyedu is a Maxillofacial Surgery Consultant and the CEO of the Cape Coast Teaching Hospital. He is also a Fellow of the Ghana College of Physicians and Surgeons. It has been his long-standing passion to contribute to National health policy aimed at improving the healthcare sector in Ghana. Additionally, as a dedicated antibiotic steward who has garnered management support for antimicrobial stewardship in my institution, he is committed to contributing to research to help tackle the AMR situation in Ghana and curb this global threat.
Eric is a member of ISAC Member Society the British Society of Antimicrobial Chemotherapy (BSAC).

BIANCA GRAVES, Herston Hospital Campus, Brisbane, Australia
Antimicrobial Resistance in Honiara, Solomon Islands
Bianca Graves is a dual trained Infectious Diseases/Clinical Microbiology Specialist from Brisbane, Australia. She is currently a Microbiology Registrar at Pathology Queensland. Prior to this, she was a Public Health Registrar at Centre for Disease Control Darwin. She is passionate about enhancing microbiology laboratory capacity in the Pacific region to improve antimicrobial resistance surveillance and patient outcomes. 
Bianca  s a member of ISAC Member Society the Australian Society of Antimicrobials (ASA).

We look forward to seeing the results of these exciting projects.